CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Solutions For CQA Analysis Of IVT mRNA-Based Biotherapeutics

  Discover new innovative solutions for mRNA analysis, enhancing accuracy and efficiency in IVT mRNA workflows, including advanced technologies and methodologies to optimize your research and development processes.

• Surveying Amino Acid Variability Among CHO Media

  Variability in amino acid levels across CHO media can affect growth and product quality. Learn why real-time monitoring and proactive control strategies are key to improving process consistency.

• Optimized Product Recovery Using The Drug Product Filtration System

  Explore strategies to maximize drug product recovery during sterile filtration, minimize hold-up volume, and reduce dilution after PUPSIT to ensure higher yield, improved efficiency, and less waste.

• The Need For Adaptive Distribution Partners For Cell And Gene Therapies

  Optimize your commercial strategy by exploring how adaptive distribution models navigate reimbursement challenges and improve patient access. Partner early to align workflows and ensure operational success.

• Nucleic Acid-LNP Ultrafiltration And Diafiltration

  Downstream filtration can make or break LNPs at scale. See how membrane format, loading, and shear affect recovery and stability — and how alternative TFF lowers scale‑up risk.

• Mold In Cleanrooms: A Persistent Threat And The Case For Proactive Bio-Decontamination

  Learn how a comprehensive investigation and systems-level bio-decontamination strategy successfully eliminated persistent mold contamination in a vaccine manufacturing facility's high-risk area.

• Use Cation Exchange Chromatography For High Yields In Vaccine Production

  Learn how to achieve high yields in vaccine production by using Cation Exchange Chromatography for purifying SARS-CoV-2 spike proteins. This method provides high purity and minimizes protein aggregates.

• GLP-1 Peptides Around The World

  Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.

• Novel Cardiotoxicity Evaluation Method Using iPS-Derived Cardiomyocytes

  Discover how real-time monitoring of glucose and lactate in iPS-derived cardiomyocytes reveals subtle drug-induced metabolic shifts that traditional screening methods often fail to detect.

• Supporting Global Approval Of A First-In-Class Gene Therapy For A Rare Genetic Disorder

  Global approvals for a first-in-class gene therapy don’t happen by chance. See how adaptive oversight and inspection readiness kept a complex rare disease program moving forward.